WELCOME TO The government REPORT
Newsletter | Member Login | Signup
Home > Companies > City of Blue Springs
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Cybersecurity
Carahsoft | August 05, 2022
CornerstoneAI, Provider of Ethical and Responsible AI Services and Solutions, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced a partnership. Under this agreement, Carahsoft will serve as CornerstoneAI’s Master Government Aggregator®, making their artificial intelligence (AI) and machine learning (ML) solutions available to the Public Sector through Carahsoft’s reseller partners and NASA Solutions for Enterprise-Wide Procurement (...
QuoLab Technologies | April 18, 2022
QuoLab Technologies, provider of a data-centric security operations platform (SOP), announced its partnership with B Technology, an Austin, Texas-based IT infrastructure and cyber security solutions provider. B Technology will serve as an official reseller of the QuoLab platform, helping the company to extend its reach to both commercial and government entities. Now more than ever, strong security is a requirement for every organization. This partnership will...
Government Business
iQor | April 07, 2022
The Philippines Department of Labor and Employment (DOLE) has recognized iQor Santa Rosa with the Government Safety Seal Certification for the BPO sector in the province of Laguna. This is the second such certification for iQor, which was the first BPO to receive this recognition in Region 4A (Calabarzon Region) when iQor Dasmarinas received the certification. Companies in the manufacturing, utilities, and business process outsourcing (BPO) industries are eligible for the certification based on ...
Merck | December 22, 2021
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine. In the U.K., LAGEVRIO® is the planned trademark for molnupiravir; the trademark for molnupiravir in other countries has not been approved. With this additional procurement agreement, which follows a previously announced...
Article
infographic
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE